Search results
Results from the WOW.Com Content Network
WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017. [6] As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore. [7] In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong. [8]
Insilico Medicine is a biotechnology company based in Pak Shek Kok, Hong Kong in Hong Kong Science Park near the Chinese University of Hong Kong, [2] and in New York, at The Cure by Deerfield. The company combines genomics, big data analysis, and deep learning for in silico drug discovery. [3] [4] [5]
WuXi PharmaTech was founded in December 2000 in Shanghai by organic chemist Ge Li. [1] [2]The company opened chemistry facilities in Tianjin in 2007. In 2008, WuXi PharmaTech acquired AppTec Laboratory Services Inc., a US-based company founded in 2001 with expertise in medical-device and biologics testing and with facilities in St. Paul, MN; Philadelphia, PA; and Atlanta, GA.
Location of Hong Kong. Hong Kong is an autonomous territory of the People's Republic of China on the Pearl River Delta of East Asia. [1] Hong Kong is one of the world's most significant financial centres, with the highest Financial Development Index score and consistently ranks as the world's most competitive and freest economic entity.
HKSTP manages facilities and provides value-added services for the technology, research and development sector in Hong Kong. [1] These facilities include Hong Kong Science Park (for technology companies), InnoCentre (for design enterprises), and three industrial estates at Tai Po, Yuen Long and Tseung Kwan O (for a range of skill-intensive business sectors). [1]
GenScript Biotech, fully known as GenScript Biotech Corporation, usually referred to as simply GenScript, is a New Jersey–based biotech company. [3] [4] [5] It was co-founded in 2002 in New Jersey by Fangliang Zhang, Ye Wang, and Luquan Wang. [6] The company mainly provides life science research application instruments and services. [7]
CBC is headquartered in Singapore with additional offices Shanghai, Beijing, Hong Kong, New York and Seoul. [6] [7] [11] Notable deals of CBC include the successful listing of Everest Medicines on Hong Kong Stock Exchange in 2020 and the privatization of South Korean company, Hugel for $1.4 billion. [8] [9]
The company was known as Hong Kong Pharmaceutical Holdings Limited (or just Hong Kong Pharmaceutical; Chinese: 香港葯業 or 香港藥業 or just 港葯/港藥) from 2000 to 2007. It was previously known as "N P H International Holdings Limited" from 1997 to 2000, [ 2 ] : 11 as well as Nam Pei Hong International Holdings Limited in 1997. [ 3 ]